[Report on 7th International Meeting on Hepatitis C and related viruses, Gold Coast, Australia].
Aizaki
H
H
Department of Virology II, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Matsuura
Y
Y
D000998:Antiviral Agents; D001315:Australia; D016174:Hepacivirus / Q000235:genetics / Q000472:pathogenicity; D006526:Hepatitis C / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007391:International Cooperation; D014176:Protein Biosynthesis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D014761:Viral Hepatitis Vaccines; D017361:Viral Nonstructural Proteins; D014779:Virus Replication
D000998:Antiviral Agents; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; D014761:Viral Hepatitis Vaccines; D017361:Viral Nonstructural Proteins; C069130:nucleocapsid protein, Hepatitis C virus